SCHEMBL5044221

SCHEMBL5044221

OCCCN1CC2C(CO)C2C1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 5/20 0.39
GLB1 P16278 1/20 0.33
PYGL P06737 1/20 0.33
GUSB P08236 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3429997 0.83 GBA1 (0.33) GBA1GLB1
SCHEMBL20109895 0.77 GBA1 (0.39) GBA1GLB1GUSB
SCHEMBL14827671 0.74 ALDH1A1 (0.37) GBA1GLB1PYGL
SCHEMBL17809705 0.72 GBA1 (0.36) GBA1GLB1GUSB
SCHEMBL16216895 0.72 GBA1 (0.36) GBA1GLB1GUSB
SCHEMBL19636877 0.71 GBA1 (0.37) GBA1GLB1PYGLGUSB
SCHEMBL2769503 0.71 GBA1 (0.37) GBA1GLB1PYGLGUSB
SCHEMBL14968077 0.71
SCHEMBL21736599 0.70
SCHEMBL8259911 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613619-B1 QUINAZOLINE DERIVATIVES FOR TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-03-26 EP disclosed